Sonntag, 27. September 2015
Symposium Spectranetics GmbH
Evidence and promises from next gen DCBs in the SFA:
The Stellarex case example
13:00 - 14:30 Vorsitz: T. Zeller, Bad Krozingen
  Saal K2-4  
13:00 - 13:20
ILLUMENATE FIH: a 2-year sustained benefit
W. Ito, Immenstadt
13:20 - 13:40
Role of Photoablation in the era of drug elution
C. Wissgott, Heide
13:40 - 14:00
Treating calcium while leaving nothing behind: combination of plaque incision
and DCB
E.Blessing, Karlsbad
14:00 - 14:20
Stellarex cost economic value proposition within the German healthcare system
T.Zeller, Bad Krozingen
14:20 - 14:30
Diskussion
 
« Übersicht